DMRA
Damora Therapeutics, Inc. has filed 329 documents with the SEC between 2020 and 2026. The most frequent type is insider trade (103 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| New insider ownership | 3 | 2024-10-11 | 2024-10-07 |
| Major company event | 8-K | 2024-10-07 | 2024-10-07 |
| Major company event | 8-K | 2024-09-18 | 2024-09-16 |
| Major company event | 8-K | 2024-09-11 | 2024-09-10 |
| Major company event | 8-K | 2024-09-05 | 2024-08-29 |
| Passive ownership stake (update) | SC 13G/A | 2024-08-29 | - |
| New insider ownership | 3 | 2024-08-16 | 2024-08-12 |
| Quarterly report | 10-Q | 2024-08-12 | 2024-06-30 |
| Activist ownership stake (update) | SC 13D/A | 2024-06-24 | - |
| Insider trade | 4 | 2024-06-21 | 2024-06-20 |
| Insider trade | 4 | 2024-06-21 | 2024-06-20 |
| Insider trade | 4 | 2024-06-21 | 2024-06-20 |
| Major company event | 8-K | 2024-06-21 | 2024-06-20 |
| Insider trade | 4 | 2024-06-21 | 2024-06-20 |
| Insider trade | 4 | 2024-06-21 | 2024-06-20 |
| Proxy statement | DEF 14A | 2024-04-29 | 2024-06-20 |
| Quarterly report | 10-Q | 2024-04-29 | 2024-03-31 |
| PRE 14A | - | 2024-04-16 | 2024-06-20 |
| Major company event | 8-K | 2024-03-26 | 2024-03-22 |
| Employee stock plan | S-8 | 2024-03-08 | - |
| Annual report | 10-K | 2024-03-08 | 2023-12-31 |
| SCHEDULE 13G/A | - | 2024-02-09 | - |
| Insider trade | 4 | 2024-01-05 | 2024-01-03 |
| Insider trade | 4 | 2024-01-05 | 2024-01-03 |
| Insider trade | 4 | 2024-01-05 | 2024-01-03 |
| Major company event | 8-K | 2023-12-21 | 2023-12-21 |
| Quarterly report | 10-Q | 2023-11-06 | 2023-09-30 |
| Major company event | 8-K | 2023-10-23 | 2023-10-23 |
| Passive ownership stake | SC 13G | 2023-10-03 | - |
| Major company event | 8-K | 2023-10-02 | 2023-09-27 |
| Insider sale notice | 144 | 2023-10-02 | - |
| Insider sale notice | 144 | 2023-10-02 | - |
| Insider sale notice | 144 | 2023-10-02 | - |
| Insider sale notice | 144 | 2023-10-02 | - |
| Major company event | 8-K | 2023-09-26 | 2023-09-20 |
| Activist ownership stake (update) | SC 13D/A | 2023-09-18 | - |
| Activist ownership stake (update) | SC 13D/A | 2023-09-05 | - |
| Insider sale notice | 144 | 2023-08-30 | - |
| Insider sale notice | 144 | 2023-08-30 | - |
| Insider sale notice | 144 | 2023-08-30 | - |
| Insider sale notice | 144 | 2023-08-30 | - |
| 144/A | - | 2023-08-21 | - |
| Insider sale notice | 144 | 2023-08-21 | - |
| Insider sale notice | 144 | 2023-08-21 | - |
| Insider sale notice | 144 | 2023-08-21 | - |
| Insider sale notice | 144 | 2023-08-21 | - |
| Insider trade | 4 | 2023-08-17 | 2023-08-15 |
| Activist ownership stake (update) | SC 13D/A | 2023-08-17 | - |
| Major company event | 8-K | 2023-08-15 | 2023-08-15 |
| Insider sale notice | 144 | 2023-08-15 | - |